Woodfield Clinical Consulting, LLC
has a diverse range of clients, from “big” Pharma
to small “start-ups”. It has also accomplished
a number of varied tasks for them. For Bristol-Myers Squibb
we were instrumental in the filing of the NDA for Pravigard®
and the preparation for the FDA Cardio-Renal Advisory Committee.
For some of the smaller companies it has been the filing of
the IND and the design of the “First in Man Study”
with the follow-up rising multiple dose study and choice of
the appropriate “biomarker”. Such a choice enables
one to gain an understanding of what the duration of the clinical
effect might be and what dose would be required to see it.
Reviews of licensing opportunities make use of Dr. Ford’s
knowledge of medicinal chemistry. He can often immediately
grasp how the new compound fits into the “prior art”. His knowledge of clinical methodology permits him
to provide a clinical plan of how to demonstrate its clinical profile. You will also be provided with a fair and balanced appraisal of its therapeutic